TRUFILL N-BUTYL CYANOACRYLATE (NBCA) LIQUID EMBOLIC SYSTEM

Tissue Adhesive For Use In Embolization Of Brain Arteriovenous Malformations

FDA Premarket Approval P990040 S004

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for revisions to the product label regarding use of the product under high flow conditions, and with ratios of contrast reagent and nbca outside of those ratios tested in the clinical study.

DeviceTRUFILL N-BUTYL CYANOACRYLATE (NBCA) LIQUID EMBOLIC SYSTEM
Classification NameTissue Adhesive For Use In Embolization Of Brain Arteriovenous Malformations
Generic NameTissue Adhesive For Use In Embolization Of Brain Arteriovenous Malformations
ApplicantCODMAN & SHURTLEFF, INC.
Date Received2006-04-28
Decision Date2006-06-01
PMAP990040
SupplementS004
Product CodeKGG
Advisory CommitteeNeurology
Supplement TypeSpecial (immediate Track)
Supplement ReasonLabeling Change - Indications/instructions/shelf Life/tradename
Expedited ReviewNo
Combination Product No
Applicant Address CODMAN & SHURTLEFF, INC. 325 Paramount Drive raynham, MA 02767-0350

Supplemental Filings

Supplement NumberDateSupplement Type
P990040Original Filing
S029 2019-02-19 Normal 180 Day Track
S028 2018-11-15 30-day Notice
S027 2018-11-02 Normal 180 Day Track No User Fee
S026 2018-05-29 30-day Notice
S025 2017-06-08 30-day Notice
S024 2017-01-31 Normal 180 Day Track
S023 2016-11-14 30-day Notice
S022 2016-04-18 Normal 180 Day Track
S021 2015-08-28 30-day Notice
S020 2015-02-18 Real-time Process
S019 2014-09-17 Real-time Process
S018
S017 2013-09-16 135 Review Track For 30-day Notice
S016 2010-11-24 30-day Notice
S015 2010-11-08 Real-time Process
S014 2010-10-12 30-day Notice
S013 2010-08-18 135 Review Track For 30-day Notice
S012 2010-07-28 Real-time Process
S011 2010-05-10 30-day Notice
S010 2009-11-13 30-day Notice
S009 2009-08-31 Normal 180 Day Track No User Fee
S008 2009-03-13 30-day Notice
S007 2008-12-19 30-day Notice
S006 2007-11-01 30-day Notice
S005 2007-07-20 135 Review Track For 30-day Notice
S004 2006-04-28 Special (immediate Track)
S003 2006-02-09 30-day Notice
S002 2006-02-09 30-day Notice
S001 2001-03-01 Normal 180 Day Track

NIH GUDID Devices

Device IDPMASupp
10886704029151 P990040 001
10886704029144 P990040 001
10886704085324 P990040 031
10886704085317 P990040 031

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.